Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Current Cancer Drug Targets|February 20, 2007
Costimulation, coinhibition and cancerBrant A Inman, Xavier Frigola, Haidong Dong, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 28, 2009
TLR3-stimulated dendritic cells up-regulate B7-H1 expression and influence the magnitude of CD8 T cell responses to tumor vaccinationVesna Pulko, Xin Liu, Christopher J Krco, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 22, 2007
Targeting molecular and cellular inhibitory mechanisms for improvement of antitumor memory responses reactivated by tumor cell vaccineW Scott Webster, R Houston Thompson, Kimberley J Harris, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 23, 2008
Questionable relevance of gamma delta T lymphocytes in renal cell carcinomaBrant A Inman, Xavier Frigola, Kimberley J Harris, et al.Cancer|March 7, 2007
PD-L1 (B7-H1) expression by urothelial carcinoma of the bladder and BCG-induced granulomata: associations with localized stage progressionBrant A Inman, Thomas J Sebo, Xavier Frigola, et al.Immunology Letters|December 6, 2011
Soluble B7-H1: differences in production between dendritic cells and T cellsXavier Frigola, Brant A Inman, Christopher J Krco, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 2011
Identification of a soluble form of B7-H1 that retains immunosuppressive activity and is associated with aggressive renal cell carcinomaXavier Frigola, Brant A Inman, Christine M Lohse, et al.Cancer|May 19, 2006
Mononuclear cell infiltration in clear-cell renal cell carcinoma independently predicts patient survivalW Scott Webster, Christine M Lohse, R Houston Thompson, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2008
Tumor cell and tumor vasculature expression of B7-H3 predict survival in clear cell renal cell carcinomaPaul L Crispen, Yuri Sheinin, Timothy J Roth, et al.Cancer Research|August 10, 2007
B7-H3 ligand expression by prostate cancer: a novel marker of prognosis and potential target for therapyTimothy J Roth, Yuri Sheinin, Christine M Lohse, et al.Pageof 2